Botanix Pharmaceuticals Limited (ASX:BOT)
Australia · Delayed Price · Currency is AUD 0.0540
-0.0010 (-1.82%)
Mar 11, 2026, 4:10 PM AEST
Botanix Pharmaceuticals Market Cap
Botanix Pharmaceuticals has a market cap or net worth of 122 million as of March 11, 2026. Its market cap has decreased by -86.64% in one year.
Market Cap
122.00M
Enterprise Value
91.46M
Revenue
21.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.05
Market Cap Chart
Since July 15, 2016, Botanix Pharmaceuticals's market cap has increased from 12.26M to 122.00M, an increase of 894.71%. That is a compound annual growth rate of 26.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 122.00M | -54.09% |
| Dec 31, 2025 | 265.72M | -66.39% |
| Dec 31, 2024 | 790.67M | 168.97% |
| Dec 29, 2023 | 293.96M | 367.07% |
| Dec 30, 2022 | 62.94M | 15.49% |
| Dec 31, 2021 | 54.50M | -55.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 15, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tetratherix | 193.42M |
| Starpharma Holdings | 161.67M |
| Actinogen Medical | 146.60M |
| Island Pharmaceuticals | 125.28M |
| Recce Pharmaceuticals | 124.35M |
| Paradigm Biopharmaceuticals | 109.81M |
| Arovella Therapeutics | 88.12M |
| Radiopharm Theranostics | 81.52M |